`

Genexine, Inc

Biotechnology Research

Specialities :
Innovative bio medicine
Long-acting fc fusion protein: hyfc platform
And therapeutic dna vaccines in oncology
revenue-icon Revenue
1M - 10M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About Genexine, Inc

What does Genexine, inc do?+

Genexine has robust R&D pipelines in clinical and pre-clinical stages based on long-acting Fc-fusion technology and therapeutic DNA vaccine technology. In the clinical stage, Genexine has GX-H9 (long-acting human growth hormone, hGH-hyFc) co-developed with Handok for both adult and pediatric GHD, currently finished multinational Phase 2 trials and preparing for global Phase 3 trials. GX-188E therapeutic DNA vaccine for HPV-associated diseases is in Phase 2 in Europe and Korea for Cervical Intraepithelial Neoplasia II/III. Combined with Mercks Keytruda, GX-188E recently is in Phase 1b/2a trial for cervical cancer. HyLeukin-7 (Immuno-oncology agent, IL-7-hyFc) has finished Phase 1 trial in Korea and...

What are Genexine, inc's specialties? +

Innovative bio medicine,long-acting fc fusion protein: hyfc platform,and therapeutic dna vaccines in oncology

What is Genexine, inc's industry? +

Genexine, inc operates in the Biotechnology research industry.

What is Genexine, inc's revenue? +

Genexine, inc's revenue is 1m - 10m

What is Genexine, inc's company size? +

Genexine, inc has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.